Kayne Anderson Rudnick Investment Management LLC Charles River Laboratories International, Inc. Transaction History
Kayne Anderson Rudnick Investment Management LLC
- $43.7 Billion
- Q3 2024
A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 1,939,825 shares of CRL stock, worth $360 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
1,939,825
Previous 1,908,989
1.62%
Holding current value
$360 Million
Previous $394 Million
3.1%
% of portfolio
0.87%
Previous 0.99%
Shares
27 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
52.2MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.13 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$945 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$695 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$396 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.76MShares$327 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.45B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...